EGFRvIII targeted aptamer-drug conjugate therapy (Aptamer Sciences/Pinotbio)

N/A

Report date: 2024/01/12 17:54:09

Base Information

Drug NameEGFRvIII targeted aptamer-drug conjugate therapy (Aptamer Sciences/Pinotbio)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor variant III modulators
TargetsEpidermal growth factor receptor variant III
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAptamer Sciences IncPinotbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAptamer Sciences IncPinotbio Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A